News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cipla Ltd. Focuses its China Investment, Emphasizes Biosimilars


8/14/2012 9:40:55 AM

by Richard Daverman, PhD

August 13, 2012 -- Cipla, the Indian generic drug maker, pulled $72 million out of its 49% investment in China’s Desano Holdings, and then put between $20 million and $25 million into each of three Desano subsidiaries in which Cipla is already invested. The companies focus on biosimilars, API and finished drugs. The goal of the narrowed focus is to become more vertically integrated. More details....

Stock Symbol: (BSE: 500087)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES